Our Focus

Our focus is to strengthen respiratory prevention by translating scientific evidence into policy — confronting the system-level barriers that keep proven prevention from reaching people across whole populations and every stage of life. By bringing together scientific, clinical, and policy expertise, we work to close the gap between what prevention can achieve and what it delivers in practice.

Why Respiratory Prevention Matters

Respiratory infections remain a defining challenge for health systems worldwide, from seasonal influenza and RSV to emerging pandemic threats. Prevention remains the most effective way to reduce severe illness, hospitalization, and pressure on health systems. A LifeCourse approach supports timely vaccination, early detection, and preparedness, recognizing that risk and exposure shift across every stage of life.

Why Prevention Falls Short in Practice

Effective respiratory prevention strategies are well established, yet translating them into consistent population-level impact proves difficult. Prevention is often fragmented across programs, age groups, and life stages, and access to vaccination and early care is uneven. Approaches built around specific risk groups rather than whole populations leave many people unprotected, and gains in one setting rarely extend across the system.

From Evidence to Implementation

Addressing these challenges requires moving from isolated prevention measures toward coordinated, system-level strategies. This means bringing together evidence and policy-relevant insights, from vaccination across every stage of life to surveillance and the control of transmission, and highlighting the role of coverage, coordination, and system design in reducing disease burden and building population-level resilience.

Resources

Insights, Reports & Expert Perspectives

Explore a collection of policy briefings, expert interviews, reports and newsletters from the LifeCourse Prevention Initiative.

The Hidden Burden of Respiratory Viruses in Older Adults

Respiratory viruses in older adults, the systemic consequences of infection, and the case for expanding vaccination programs as a health system imperative.
December 5, 2025

Navigating Vaccination in Marginalized and Religious Communities

How trust and mistrust shape vaccination decisions in marginalized religious communities and practical approaches to sharing responsibility for community health.
December 5, 2025

Strategies Against RSV, Influenza, and SARS-CoV-2

The burden of RSV, influenza, and SARS-CoV-2, the systemic complications these viruses trigger, and the case for lifelong integrated immunization strategies.
December 5, 2025

Treatment for Seasonal Respiratory Diseases, Diagnosis and Antibiotic Stewardship

Diagnostic uncertainty in respiratory infections and evidence-based approaches for antibiotic stewardship to combat resistance.
November 29, 2024

Trends in Respiratory Illnesses and the Landscape of Preventive Interventions

Current respiratory syncytial virus epidemiology and breakthrough preventive options, including vaccines and monoclonal antibodies across the lifecourse.
November 29, 2024

Bronchiolitis and Pneumonia in the ICU: Severe Cases and Outcomes

Clinical analysis of severe bronchiolitis and pneumonia cases requiring intensive care intervention, examining treatment protocols, long-term consequences, and strategies to improve patient outcomes.
November 29, 2024

The Burden of Bronchiolitis and Pneumonia in Primary Care

Resource utilization and clinical management of bronchiolitis and pneumonia in community settings, with practical insights for optimizing primary care response.
November 29, 2024

The Impact of Bronchiolitis and Pneumonia on Child Health and Families

The burden of bronchiolitis and pneumonia on families, emotional, financial, and social implications alongside clinical consequences.
November 29, 2024

RSV In Young Infants- New Paths for Immunisation

Approaches to protect infants from RSV, recent advancements in maternal immunization and passive antibody protection strategies for newborns.
December 1, 2023

Interview: Strategy Matters - How to Protect Every Infant

Susanna Esposito, Professor of Pediatrics at the University of Parma, cuts through the debate on RSV prevention strategies with a clear bottom line: every infant needs protection — the question is how to get there.
December 5, 2025

Interview: The RSV March - Protecting Every Baby

Prof. Roy K. Philip, Consultant Neonatologist at University Hospital Limerick, explains why RSV is so dangerous in the first months of life and shares the remarkable results of Ireland's Pathfinder program, which reduced children's ward admissions by up to 74%.
December 5, 2025

Interview: The Real Burden of RSV

Dr. Marco Del Riccio, Public Health Physician at the University of Florence, makes the case that RSV is a multisystem disease — and that cardiologists, geriatricians, and policymakers need to pay attention.
December 5, 2025

Interview: RSV and Pneumococcus- A Dangerous Combination

George Syrogiannopoulos, Professor of Pediatrics and Program Committee member of EIP, brings a dimension of RSV prevention that is often overlooked: the dangerous interaction between RSV infection and pneumococcal disease.
December 5, 2025

RSV Prevention Report 2024

This report presents findings from a survey of primary care providers and pediatricians, examining the burden of RSV across diagnosis, treatment, and prevention. It reveals rising case severity compared with prior seasons, underuse of diagnostic testing, and inconsistent vaccination recommendations. The report closes with recommendations to strengthen diagnostic capacity, standardize treatment protocols, and expand education for frontline providers.

RSV Prevention Report 2025

This policy report presents a comprehensive, evidence-based review and policy recommendations for RSV prevention in infants and young children. It draws on epidemiological data, clinical trial results, real-world effectiveness studies and the lived experiences of families affected by RSV to present a comprehensive picture of the burden this virus imposes and the strategies available to reduce it, also addressing the important and under-recognized interaction between RSV and pneumococcal disease.

May 1, 2026

Volume VI - RSV Prevention - RSV has Consequences Beyond the Respiratory System

RSV drives pneumococcal disease and shapes lung function into adulthood. Why its lasting burden is the strongest case for early universal prevention.

July 2, 2026

Volume IV - RSV Prevention - The Evidence is Clear: Universal RSV Protection Works - But Only At High Coverage

The tools for RSV prevention work; coverage decides the impact. Multi-country evidence on reaching every infant, from the 2025 LifeCourse Prevention Summit.

May 28, 2026

Volume II - RSV Prevention - RSV is Not Just a Cold; Prevention Must Therefore be Universal

Most infants hospitalized with RSV are otherwise healthy. Why universal prevention outperforms targeted strategies - insights from the 2025 LifeCourse Summit.

May 14, 2026
Focus Zones

Priority Areas Shaping the
Future of Prevention

The initiative focuses on key prevention priorities shaping health systems, policy frameworks, and long-term population outcomes across the LifeCourse.